Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. GCHNC LLC dba Hemp XR/Gate City Hemp dba Hemp XR/Allaziya Enterprises, LLC dba Hemp XR
WARNING LETTER
•GCHNC LLC dba Hemp XR/Gate City Hemp dba Hemp XR/Allaziya Enterprises, LLC dba Hemp XR•September 28, 2023

FDA WARNING_LETTER - GCHNC LLC dba Hemp XR/Gate City Hemp dba Hemp XR/Allaziya Enterprises, LLC dba Hemp XR - September 28, 2023

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

The FDA issued a Warning Letter to Alaa Odeh Mahmoud Hamed and Abdulraouf B. Allamandani, operating hemp-xr.com, after reviewing their website in September 2023. The letter identifies several Delta-8 THC and CBD-containing products as adulterated foods and subject to prohibited acts under the Federal Food, Drug, and Cosmetic Act (FD&C Act).

Specifically, multiple Delta-8 THC products, including cookies, crispy bites, gummies, and honey, are deemed adulterated under section 402(a)(2)(C)(i) of the FD&C Act because Delta-8 THC is considered an unsafe food additive, lacking FDA approval and not generally recognized as safe (GRAS). Introducing these adulterated foods into interstate commerce is prohibited under section 301(a). FDA expressed serious public health concerns regarding Delta-8 THC's unapproved status, adverse event reports, psychoactive effects, manufacturing processes, and potential appeal to children.

Similarly, the Hemp XR CBD Honey 500 MG product is adulterated under section 402(a)(2)(C)(i) as CBD is also an unsafe food additive, not GRAS, and not FDA-approved. Its introduction into interstate commerce is prohibited under section 301(a). Furthermore, introducing this CBD product is a prohibited act under section 301(ll) because CBD is an active ingredient in an approved drug and has been subject to substantial clinical investigations. FDA highlighted potential harms from CBD, including liver injury, drug interactions, and reproductive issues.

The firm must respond in writing within fifteen working days, outlining corrective actions and preventative measures, with supporting documentation. Failure to comply may lead to legal action, including seizure and injunction.

Company
GCHNC LLC dba Hemp XR/Gate City Hemp dba Hemp XR/Allaziya Enterprises, LLC dba Hemp XR
Inspection Date
September 28, 2023
Product Type
Food
Office
Center for Food Safety and Applied Nutrition
Person
  • Ann M. Oxenham (Director)
Open in Dashboard

ID · 2ab2cafb-c74e-4e27-9126-919ea81c3a2a

Violation Codes6
21 U.S.C. 342(a)(2)(C)(i)21 U.S.C. 331(ll)21 CFR 170.30(a)21 CFR 170.30(b)21 CFR 170.30(c)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.